Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease
Status:
Terminated
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether roflumilast can improve metabolic profile
and reduce visceral adiposity in patients with chronic obstructive pulmonary disease (COPD).